Alvesco approved for asthma

Alvesco approved for asthma
Alvesco approved for asthma
The FDA has approved Alvesco (ciclesonide, from Nycomed) inhalation aerosol for the prophylactic and maintenance treatment of asthma in patients ≥12 years of age. Alvesco is a lung-activated corticosteroid prodrug that inhibits multiple inflammatory cell types and chemicals associated with asthma.

For more information call (973) 514-4240 or visit www.alvesco.com.